2,538
Views
24
CrossRef citations to date
0
Altmetric
Clinical Research

Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department

, , , &
Pages 471-475 | Received 25 Jun 2019, Accepted 23 Aug 2019, Published online: 04 Sep 2019

References

  • Simonetto DA, Oxentenko AS, Herman ML, et al. Cannabinoid hyperemesis: a case series of 98 patients. Mayo Clin Proc. 2012;87(2):114–119.
  • Sorensen CJ, DeSanto K, Borgelt L, et al. Cannabinoid hyperemesis syndrome: diagnosis, pathophysiology, and treatment—a systematic review. J Med Toxicol. 2017;13(1):71–87.
  • Jones JL, Abernathy KE. Successful treatment of suspected cannabinoid hyperemesis syndrome using haloperidol in the outpatient setting. Case Rep Psychiatry. 2016;2016:1–3.
  • Hickey JL, Witsil JC, Mycyk MB. Haloperidol for treatment of cannabinoid hyperemesis syndrome. Am J Emerg Med. 2013;31(6):1003.e5–1003.e6.
  • Lee C, Greene SL, Wong A. The utility of droperidol in the treatment of cananbinoid hyperemesis syndrome. Clin Toxicol. 2019;57:773–777.
  • Richards JR, Gordon BK, Danielson AR, et al. Pharmacologic treatment of cannabinoid hyperemesis syndrome: a systematic review. Pharmacotherapy. 2017;37(6):725–734.
  • Lee LY, Abbott L, Moodie S, et al. Cyclic vomiting syndrome in 28 patients: demographics, features, and outcomes. Eur J Gastroenterol Hepatol. 2012;24(8):939–943.
  • Lapoint J, Meyer S, Yu C, et al. Cannabinoid hyperemesis syndrome: public health implications and a novel model treatment guideline. WestJEM. 2018;19(2):380–386.
  • Khattar N, Routsolias JC. Emergency department treatment of cannabinoid hyperemesis syndrome: a review. Am J Ther. 2018;25(3):e357–e361.
  • Richards JR, Lapoint JM, Burillo-Putze G. Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment. Clin Toxicol. 2018;56(1):15–24.
  • Moon AM, Buckley SA, Mark NM. Successful treatment of cannabinoid hyperemesis syndrome with topical capsaicin. ACG Case Reports J. 2018;5(1):e3.
  • Dezieck L, Hafez Z, Conicella A, et al. Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series. Clin Toxicol. 2017;55(8):908–913.
  • Graham J, Barberio M, Wang GS. Capsaicin cream for treatment of cannabinoid hyperemesis syndrome in adolescents: a case series. Pediatrics. 2017;140(6):e20163795.
  • Biar R, Oh A, Lapoint J, et al. Topical capsaicin cream used as therapy for cannabinoid hyperemesis syndrome [abstract]. Clin Toxicol. 2014;5:787.
  • Lapoint J. Capsaicin cream for treatment of cannabinoid hyperemesis syndrome [abstract]. Clin Toxicol. 2014;52:707.
  • Allen JH, de Moore GM, Heddle R, et al. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut. 2004;53(11):1566–1570.
  • Kim HS, Anderson JD, Saghafi O, et al. Cyclic vomiting presentations following marijuana liberalization in Colorado. Acad Emerg Med. 2015;22(6):694–699.
  • Habboushe J, Rubin A, Haoming L, et al. The prevalence of cannabinoid hyperemesis syndrome among regular marijuana smokers in an urban public hospital. Basic Clin Pharmacol Toxicol. 2018;122:660–662.
  • Bhandar S, Jha P, Lisdahl K, et al. Recent trends in cyclic vomiting syndrome–associated hospitalizations with liberalization of cannabis use in the state of Colorado. IMJ. 2018;49:649–655.
  • Rudd JA, Nalivaiko E, Matsuki N, et al. The involvement of TRPV1 in emesis and anti-emesis. Temperature. 2015;2(2):258–276.
  • Fernandes ES, Fernandes MA, Keeble JE. The functions of TRPA1 and TRPV1: moving away from sensory nerves. Br J Pharmacol. 2012;166(2):510–521.
  • Ramos-Perdigues S, Gordillo MJ, Caballero C, et al. Cannabinoid hyperemesis syndrome, a treatment discussion. Eur Psychiatry. 2017;41:318.
  • Haas S, Jacobs B, Schwartz M, et al. Measuring patient quality of life: time is what matters. NEJM Catalyst. 2018 [cited 2019 Apr 13; updated July 25]. Available from: https://catalyst.nejm.org/patient-quality-time-is-what-matters/

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.